Evidence map›Paper›PMID 40322676›Full record

ArticleClinical kidney journal2025

Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.

Maxime Teisseyre, Alexandre Destere, Marion Cremoni, Sonia Boyer-Suavet, Alexandre Karamé, Léa Corlu, Gabrielle Duneau, Paule Poirier, Siriane Lefevre, Kévin Zorzi and 8 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Maxime TeisseyreCentre de Référence Maladies Rares Syndrome Néphrotique Idiopathique et Glomérulonéphrite Extra-membraneuse, CHU de Nice, Université Côte d'Azur, Nice, France.
Alexandre DestereDépartement de Pharmacologie Clinique et de Pharmacovigilance, CHU de Nice, Université Côte d'Azur, Nice, France.
Marion CremoniCentre de Référence Maladies Rares Syndrome Néphrotique Idiopathique et Glomérulonéphrite Extra-membraneuse, CHU de Nice, Université Côte d'Azur, Nice, France.
Sonia Boyer-SuavetDépartement de Néphrologie et Dialyse, Centre Hospitalier d'Antibes Juan-Les-Pins, Antibes, France.
Alexandre KaraméDépartement de Néphrologie et Dialyse, Néphropôle - Médipole Hôpital Privé, Lyon Villeurbanne, Villeurbanne, France.
Léa CorluDépartement de Néphrologie et Dialyse, Centre Hospitalier de Lorient, Lorient, France.
Gabrielle DuneauFondation AUB santé Lorient, Lorient, France.
Paule PoirierDépartement de Néphrologie et Dialyse, Centre Hospitalier d'Annecy Genevois, Annecy, France.
Siriane LefevreDépartement de Néphrologie et Dialyse, Centre Hospitalier de Lorient, Lorient, France.
Kévin ZorziCentre de Référence Maladies Rares Syndrome Néphrotique Idiopathique et Glomérulonéphrite Extra-membraneuse, CHU de Nice, Université Côte d'Azur, Nice, France.
Céline FernandezCentre de Référence Maladies Rares Syndrome Néphrotique Idiopathique et Glomérulonéphrite Extra-membraneuse, CHU de Nice, Université Côte d'Azur, Nice, France.
Vesna BrglezCentre de Référence Maladies Rares Syndrome Néphrotique Idiopathique et Glomérulonéphrite Extra-membraneuse, CHU de Nice, Université Côte d'Azur, Nice, France.
Sylvia BenzakenLaboratoire d'Immunologie, CHU de Nice, Université Côte d'Azur, Nice, France.
Guillaume FavreDépartement de Néphrologie, Dialyse et Transplantation, CHU de Nice, Université Côte d'Azur, Nice, France.ORCID https://orcid.org/0000-0003-1069-4344
Milou-Daniel DriciDépartement de Pharmacologie Clinique et de Pharmacovigilance, CHU de Nice, Université Côte d'Azur, Nice, France.
Vincent L M EsnaultCentre de Référence Maladies Rares Syndrome Néphrotique Idiopathique et Glomérulonéphrite Extra-membraneuse, CHU de Nice, Université Côte d'Azur, Nice, France.
Sylvain BenitoEXACTCURE, Nice, France.
Barbara Seitz-PolskiCentre de Référence Maladies Rares Syndrome Néphrotique Idiopathique et Glomérulonéphrite Extra-membraneuse, CHU de Nice, Université Côte d'Azur, Nice, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40322676
PMCPMC12046509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.